AF
HRMY icon

Advisornet Financial’s Harmony Biosciences HRMY Stock Holding History

Advisornet Financial’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.3K Buy
1,080
+50
+5% +$1.58K ﹤0.01% 1197
2026
Q1 		$28.9K Buy
1,030
+76
+8% +$2.49K ﹤0.01% 1231
2025
Q4 		$35.7K Buy
954
+470
+97% +$15.5K ﹤0.01% 1164
2025
Q3 		$13.3K Buy
484
+410
+554% +$14.1K ﹤0.01% 1435
2025
Q2 		$2.34K Hold
74
– – ﹤0.01% 1812
2025
Q1 		$2.46K Buy
+74
New +$2.65K ﹤0.01% 1746
2024
Q1 		– Sell
-1
Closed -$32 – 2249
2023
Q4 		$32 Sell
1
-3
-75% -$84 ﹤0.01% 2410
2023
Q3 		$131 Sell
4
-1
-20% -$35 ﹤0.01% 2185
2023
Q2 		$176 Buy
+5
New +$173 ﹤0.01% 2232
2023
Q1 		– Sell
-4
Closed -$220 – 2444
2022
Q4 		$220 Buy
+4
New +$220 ﹤0.01% 2199

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisornet Financial's HRMY Position: Q2 2026 in Review

Advisornet Financial increased its Harmony Biosciences (HRMY) stake by 4.9% in Q2 2026, buying an estimated $1.58K and bringing the position to 1,080 shares worth $39.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.

Advisornet Financial first reported a position in HRMY in Q4 2022 and has held it in 10 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Advisornet Financial held 1,080 shares of Harmony Biosciences worth $39.3K as of Q2 2026.
  • Advisornet Financial bought 50 Harmony Biosciences shares in Q2 2026, an estimated $1.58K.
  • Harmony Biosciences made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1197 holding.
  • Advisornet Financial first reported a position in Harmony Biosciences in Q4 2022 and has held it in 10 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.